// App-Quantinova.ai

OP0112 : IN INDIVIDUALS AT RISK OF INFLAMMATORY ARTHRITIS, PATIENT REPORTED OUTCOMES DETERIORATE IN THE 12 WEEKS BEFORE PROGRESSION TO CLINICAL DISEASE

Researchers

Presenter

  • L. Duquenne

Principal Investigators

  • K. Mankia

  • L. Garcia-Montoya

  • J. Nam

  • A. Di Matteo

  • P. Emery

Medical Centers

  • Leeds Biomedical Research Centre, NIHR, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

Biomarkers

  • Major histocompatibility complex, class II, DR beta 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved